Tuberculosis Trial, Recruiting (NCT05539014)

Tuberculosis Trial, Recruiting NCT05539014 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT05539014 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are being treated for tuberculosis (TB) — either as an outpatient or staying in hospital — at one of the participating treatment centres
People whose TB has been confirmed through lab tests (such as sputum examination, a test called GeneXpert, or a positive culture), or through tissue analysis showing patterns typical of TB, or where a doctor has a strong clinical reason to suspect TB even if test results are not yet available
People for whom a doctor has already decided to start TB treatment

Who may not be able to join:

People who do not wish to take part in the study
People who have already been receiving anti-tuberculosis treatment for more than 7 days at the time of the enrolment visit
People who are already taking part in another research study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05539014

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

More information: https://clinicaltrials.gov/study/NCT05539014

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are being treated for tuberculosis (TB) — either as an outpatient or staying in hospital — at one of the participating treatment centres
People whose TB has been confirmed through lab tests (such as sputum examination, a test called GeneXpert, or a positive culture), or through tissue analysis showing patterns typical of TB, or where a doctor has a strong clinical reason to suspect TB even if test results are not yet available
People for whom a doctor has already decided to start TB treatment

Who may not be able to join:

People who do not wish to take part in the study
People who have already been receiving anti-tuberculosis treatment for more than 7 days at the time of the enrolment visit
People who are already taking part in another research study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

18 January 2023

Est. completion

15 October 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of patients followed for tuberculosis with unfavourable treatment outcome at month12.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov